moderna emergency use authorization

News

COVID-19, FDA and Moderna

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

STAT · 1d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

Just The News · 2d

In era of skepticism, FDA clears Moderna COVID vaccination for some kids up to 11 years old

MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

NBC4 Columbus2y

Moderna Receives FDA Authorization for Emergency Use of Omicron ...

Moderna's Bivalent Booster Shots to be Available Nationwide In Coming DaysmRNA-1273.222 Targets BA.4/.5 Strains of Omicron VariantCAMBRIDGE, MA / ACCESSWIRE / August 31, 2022 / Moderna, Inc ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

COVID-19, FDA and Moderna

Trending now